echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Roche Pharmaceuticals grants Baiyang Pharmaceutical the right to promote two oncology drugs in the Chinese mainland market

    Roche Pharmaceuticals grants Baiyang Pharmaceutical the right to promote two oncology drugs in the Chinese mainland market

    • Last Update: 2021-04-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    (Health Times reporter Dong Rui) On March 29, Shanghai Roche Pharmaceutical Co.


    (Health Times reporter Dong Rui)

    Xeloda is a basic drug in the treatment of colorectal cancer, gastric cancer and breast cancer, and has a synergistic effect with a variety of anti-tumor drugs.


    Tarceva is the first-generation molecular targeted drug for the treatment of lung cancer produced by Roche Pharmaceuticals.


    In this regard, Fu Gang, Chairman of Baiyang Pharmaceutical Group, said: “Roche Pharmaceuticals is a leading biopharmaceutical company in the world.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.